Filing Flows › Chemed (CHE) › VITAS revenue
Chemed (CHE) VITAS revenue by quarter
Chemed's VITAS revenue was $457M in Q3 2026 (third quarter 2026), +3% from Q2 2026. Over the last 7 quarters it ranged from $396M (Q2 2025) to $457M (Q3 2026).
| Quarter | VITAS revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $457M | +3% | +12% |
| Q2 2026 | $443M | +6% | +12% |
| Q1 2026 | $420M | +0.3% | +3% |
| Q4 2025 | $419M | +3% | — |
| Q3 2025 | $408M | +3% | — |
| Q2 2025 | $396M | -3% | — |
| Q1 2025 | $407M | — | — |
Q3 2026 at a glance
Chemed, Q3 2026: revenue $691M (+11% year over year), operating margin 14.0%, net earnings $71.6M, operating cash flow $56.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Chemed's VITAS revenue?
Chemed's VITAS revenue was $457M in Q3 2026 (third quarter 2026), +3% from Q2 2026.
How has Chemed's VITAS revenue changed?
Over the last 7 quarters it ranged from $396M (Q2 2025) to $457M (Q3 2026).